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Background: Oncogenic RET fusion, caused by an inversion in 
chromosome 10, was recently identified as a driver mutation for the 
development of lung adenocarcinoma (LADC). Nevertheless, the 
molecular mechanism(s) underlying the rearrangement of the RET 
locus during lung carcinogenesis are unknown.
Methods: Genomic segments containing breakpoint junctions for RET 
fusions were cloned and analyzed by genomic polymerase chain reac-
tion and genome capture sequencing using a next-generation sequencer 
to identify the mechanisms involved in DNA strand breaks and illegiti-
mate joining of DNA ends. Of the 18 cases studied, 16 were identified 
by screening 671 LADC cases and two were previously published.
Results: Almost all (17 of 18, 94%) of the breakpoints in RET were 
located within a 2.0-kb region spanning exon 11 to intron 11 and no 
breakpoint occurred within 4 bp of any other. This suggested that as 
in papillary thyroid carcinoma, DNA strand breaks formed at nonspe-
cific sites within this region trigger RET fusion. Just over half of the 
RET fusions in LADC (10 of 18, 56%) were caused by simple recip-
rocal inversion, and two DNA-repair mechanisms, namely nonho-
mologous end joining and break-induced replication, were deduced 
to have contributed to the illegitimate joining of the DNA ends.
Conclusions: Oncogenic RET fusion in LADC occurs through multi-
ple pathways and involves the illegitimate repair of DNA strand breaks 
through mechanisms different from those identified in papillary thy-
roid carcinoma, where RET fusion also functions as a driver mutation.
Key Words: Lung adenocarcinoma, Molecular target therapy, 
Personalized medicine, RET, Gene fusion, DNA strand break.
(J Thorac Oncol. 2014;9: 622–630)
Oncogenic fusion of RET (rearranged during transfection) tyrosine kinase gene partnered with KIF5B (kinesin 
family member 5B) and CCDC6 (coiled-coil domain contain-
ing 6) was identified as a novel druggable driver mutation in 
a small subset (1–2%) of patients with lung adenocarcinoma 
(LADC).1–4 Vandetanib (ZD6474) and cabozantinib (XL184), 
two U.S. Food and Drug Administration–approved inhibitors 
of the RET tyrosine kinase showed therapeutic responses in a 
few patients with RET fusion-positive LADC.5,6 Several clini-
cal trials are currently underway to examine the therapeutic 
effects of RET tyrosine kinase inhibitors, including these two 
drugs.7,8 RET fusions are generated by pericentric (includes 
the centromere, with a breakpoint in each arm) and paracentric 
(not including the centromere, with both breaks in the same 
arm) inversions of chromosome 10 (Fig. 1A). As the majority 
of RET fusion-positive patients are never-smokers,3,9,10 ciga-
rette smoking does not cause a predisposition. Therefore, the 
mechanism(s) responsible for the rearrangement of the RET 
locus are unknown. Elucidation of such a mechanism(s) may 
help to identify risk factors that can be modified or other pre-
ventive methods that can reduce the incidence of LADC; how-
ever, no such mechanism has been identified.8
Analyzing the breakpoints and structural aberrations 
in cancer cell genomes is a powerful method of identifying 
the underlying molecular mechanism(s) responsible, as the 
breakpoints retain “traces” of the DNA strand breaks and the 
illegitimate joining of DNA ends.11–13 In fact, several studies 
have characterized the structure of the breakpoints responsible 
for the ELE1 (also known as RFG, NCOA4, and ARA70)-RET 
oncogenic fusion in cases of papillary thyroid cancer (PTC), 
including post-Chernobyl irradiation-induced cases, to elu-
cidate the mechanism underlying chromosome 10 inversion 
generating this fusion (Fig. 1A).14–17
Here, we examined the molecular processes underlying 
chromosome inversions that generate oncogenic RET fusions 
in LADC by cloning genomic segments containing breakpoint 
junctions and by comparing their structures with those identi-
fied in PTC. The results will increase our understanding of 
how RET fusions are generated and will also have implica-
tions for diagnosis of RET fusion-positive LADCs.
PATIENTS AND METHODS
Patient Samples
Fourteen frozen tissues (13 surgical specimens and a 
pleural effusion) and two methanol-fixed  paraffin-embedded 
tissues from surgical specimens were obtained from the 
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FIGURE 1. RET fusions. A, Upper: location of the RET oncogene and its fusion-partner genes KIF5B, CCDC6, and ELE1 on chromo-
some 10. The KIF5B-RET fusion is generated in LADC, whereas the CCDC6-RET fusion is generated in LADC and PTC. The ELE1-RET 
fusion is frequent in radiation-induced PTC. Lower: LOH analysis. Allelic imbalance at SNP sites proximal and distal to the breakpoints 
were examined by MassArray analysis in three LADC cases with putative nonreciprocal inversions. Cases 11, 15, and 16 exhibited 
allelic imbalance (23%, 41%, and 29%, as indicated by arrows) at SNP loci proximal to the breakpoints, consistent with the fact that 
these samples have 20% to 40% tumor content. B, Fractions of KIF5B-RET fusion variants in LADCs. Fractions comprise the cohort 
from this study and eight published cohorts. Fractions in patients from Japan, other Asian countries (Korea and China), and the 
United States are shown below. LADC, lung adenocarcinoma; PTC, papillary thyroid carcinoma; LOH, loss of heterozygosity.
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National Cancer Center (NCC) Biobank. These samples were 
from patients with LADC who received therapy at the NCC 
Hospital (Tokyo, Japan) between 1997 and 2012. All fro-
zen samples were confirmed to be positive for KIF5B-RET 
fusion by reverse-transcriptase polymerase chain reaction 
(PCR) analysis, according to a previously described method.3 
CCDC6-RET fusion was detected by fusion fluorescence in 
situ hybridization (FISH) analysis of paraffin-embedded tis-
sues using RET- and CCDC6-specific probes (Chromosome 
Science Labo Inc., Sapporo, Japan). This study was approved 
by the Institutional Review Board of the NCC.
Cloning and Sequencing of DNAs 
Containing Breakpoint Junctions
Genomic DNAs were extracted from cancer and non-
cancerous tissues using the QIAamp DNA Mini Kit or 
the QIAamp DNA Micro Kit (Qiagen, Hilden, Germany). 
Genomic DNA fragments containing breakpoint junctions 
were amplified by genomic PCR using primers that hybrid-
ized within the KIF5B and RET loci. PCR products spe-
cifically amplified in samples of interest were subjected 
to direct Sanger sequencing. The primers used are listed in 
Supplementary Table 1 (Supplementary Digital Content 1, 
http://links.lww.com/JTO/A541).
Genome-Capture Deep Sequencing Using 
a Next-Generation Speed Sequencer
Nucleotide sequences of CCDC6-RET fusion break-
points were examined by targeted genome capture and mas-
sively parallel sequencing using an Ion Torrent Personal 
Genome Machine (Ion Torrent PGM) sequencing system and 
the Ion TargetSeq Custom Enrichment Kit (Life Technologies, 
Carlsbad, CA). One microgram of genomic DNA was subjected 
to enrichment using the probes listed in Supplementary Table 
2 (Supplementary Digital Content 1, http://links.lww.com/JTO/
A541). The mean depth of sequencing was approximately 1000.
Analysis of Sequence Reads Obtained 
by a Second-Generation Sequencer
Sequence reads were analyzed using a program devel-
oped by the authors. Briefly, reads were mapped to sequences 
of the RET and CCDC6 genes using the Burrows-Wheeler 
Aligner, Smith-Waterman alignment (BWA-SW) software18 
to detect reads that mapped to both the RET and CCDC6 
genes. Breakpoints were extracted from the local alignment 
results of BWA-SW. The detailed procedure is described in 
Supplementary Notes (Supplementary Digital Content 2, http://
links.lww.com/JTO/A542). Structures of breakpoint junctions 
were verified by Sanger sequencing of genomic PCR products.
Loss of Heterozygosity Analysis
Genomic DNAs obtained from cancerous and noncancer-
ous tissues were subjected to single nucleotide polymorphism 
(SNP) genotyping using the Illumina HumanOmni1 2.5M Chip 
(Illumina, San Diego, CA). Based on the B-allele frequencies 
obtained using the Illumina GenomeStudio software, loss of het-
erozygosity (LOH) regions in RET and surrounding regions were 
deduced. Representative SNP loci were subjected to analysis 
of allelic imbalance using the Sequenom MassARRAY system 
(Sequenom, San Diego, CA).
Analysis of Nucleotide Sequences
Nucleotide sequence analysis, including search for 
sequence homology, was performed using the  Genetyx-SV/RC 
Ver 8.0.1. software (Genetyx, Tokyo, Japan). Information about 
the distribution of repetitive elements, GC contents, conserva-
tion, DNA methylation, DNase sensitivity, and histone modi-
fication within the RET gene was obtained using the UCSC 
genome browser  (http://genome.ucsc.edu/cgi-bin/hgGateway).
RESULTS
KIF5B-RET Fusion Variations in LADC
In our previous study, six of 319 LADC cases (1.9%) 
carried KIF5B-RET fusions.3 In this study, we examined 
KIF5B-RET fusion by reverse-transcriptase PCR in a further 
352 LADC cases and found eight additional KIF5B-RET 
fusion-positive cases. In total, 14 of 671 cases (2.1%) were 
positive for KIF5B-RET fusions (cases 1–4 and 7–16 in Table 1 
and Supplementary Table 3, Supplementary Digital Content 1, 
http://links.lww.com/JTO/A541), and this frequency was con-
sistent with those reported for other cohorts.9,10,19
Among those 14 cases, 10 (71%) contained a fusion 
of KIF5B exon 15 to RET exon 12 (K15;R12), whereas the 
remaining four each contained other variants. Thus, K15;R12 
is the most frequent variant (Fig. 1B). The prevalence of the 
K15;R12 variant (45 of 60, 75%) was verified in a total of 
60 cases, including 46 cases from eight other cohorts pub-
lished to date1–4,9,10,19,20 (Fig. 1B, Supplementary Table 4, 
Supplementary Digital Content 1, http://links.lww.com/JTO/
A541). This preference was similar among cohorts from 
Japan, other Asian countries, and the United States (p > 0.05 
by Fisher’s exact test).
Distribution of Breakpoints in 
the RET and KIF5B Genes
To explore the molecular processes underlying RET 
fusion in LADC, we examined the location (clustering) of 
the breakpoints and the structure of the breakpoint junc-
tions; information about the former enabled us to deduce the 
genomic or chromosomal features that make DNA susceptible 
to strand breaks, whereas information about the latter enabled 
us to deduce the mechanism underlying the illegitimate join-
ing of DNA ends by DNA repair pathways.
The locations of the 28 breakpoints in the 14  KIF5B-RET 
fusion-positive cases mentioned above were identified by 
Sanger sequencing analysis of genomic PCR products and 
mapped (yellow arrowheads in Fig. 2A and B). The break-
points in a single Korean case from another study were also 
identified and mapped (orange arrowheads in Fig. 2A; case 
17 in Table 1). Consistent with the predominance of K15;R12 
variants, most of the breakpoints were mapped to intron 11 
of RET and intron 15 of KIF5B (Fig. 2, detailed information 
in Supplementary Table 5, Supplementary Digital Content 1, 
http://links.lww.com/JTO/A541).
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None of the RET and KIF5B breakpoints mapped at 
the same position, and no breakpoint was within 6 bp of 
another. To further investigate the breakpoint clustering, we 
mapped breakpoints in three cases of CCDC6-RET fusion, 
a minor fusion variant (cases 5, 6, and 18 in Table 1 and 
Supplementary Table 3, Supplementary Digital Content 1, 
http://links.lww.com/JTO/A541). Two of these cases were 
primary tumors, diagnosed by break apart and fusion FISH, 
and their breakpoints were determined by genome-capture 
deep sequencing of genomic DNAs using a second-generation 
sequencer. The remaining case was a LADC cell line from a 
Japanese patient, for which the breakpoints had previously 
been determined by the same method.21 Two breakpoints 
and one breakpoint in the RET gene were mapped to intron 
11 and exon 11, respectively (green arrowheads in Fig. 2), 
and no breakpoint was located within 5 bp of another. In 
total, a 2.0-kb region spanning exon 11 to intron 11 of RET 
and a 5.6-kb region spanning intron 15 of KIF5B (10 of 15, 
75%) contained the majority of breakpoints (17 of 18 [94%] 
and 10 of 15 [75%], respectively), and these breakpoints 
FIGURE 2.  Breakpoint analysis. A, 
Distribution of breakpoints in the 
CCDC6, KIF5B, and RET genes. Yellow 
arrowheads indicate the locations of 
breakpoints for KIF5B-RET fusions in 
Japanese cases (cases 1–4 and 7–16 
in Table 1), whereas the orange 
arrowhead indicates the breakpoints 
in a single Korean case (case 17). 
Green arrowheads indicate the loca-
tions of breakpoints of CCDC6-RET 
fusions in three Japanese cases (cases 
5, 6, and 18). Arrowheads for ever-
smoker LADC cases are hatched. 
Gray and black arrowheads indicate 
breakpoints of RET-ELE1 fusion in 38 
 radiation-induced post-Chernobyl 
PTCs and six sporadic PTCs, respec-
tively.14–17 B, Electropherograms 
for Sanger sequencing of genomic 
fragments encompassing KIF5B-RET 
breakpoint junctions. PCR products 
were directly sequenced. Examples of 
three fusion patterns (joined without 
any nucleotide insertions or overlaps, 
joined with a nucleotide insertion, and 
joined with three nucleotide overlap) 
are shown. Inserted and overlapping 
nucleotides at breakpoint junctions are 
indicated, respectively, by the blue and 
red boxes. C, Electropherogram for 
Sanger sequencing of genomic frag-
ments encompassing CCDC6-RET and 
 RET-CCDC6 breakpoint junctions. LDAC, 
lung adenocarcinoma; PCR, polymerase 
chain reaction; PTC, papillary thyroid 
carcinoma.
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were at least 5 bp from each other. Breakpoints within exon 
11 to intron 11 of RET and intron 15 of KIF5B were not 
distributed in an evidently biased manner, nor did they 
exhibit any particular nucleotide sequence or composition 
(Supplementary Table 5, Supplementary Digital Content 1, 
http://links.lww.com/JTO/A541). Therefore, DNA strand 
breaks triggering oncogenic RET fusions in LADC occur 
preferentially in a few defined regions, but at nonspecific 
sites within those regions.
Reciprocal and Nonreciprocal 
Inversions Causing RET Fusions
To explore the modes of DNA end joining that give rise 
to RET fusion, we investigated the structures of RET fusion 
breakpoint junctions. To address whether chromosome inver-
sion events were reciprocal, we cloned genomic segments con-
taining reciprocal breakpoint junctions (i.e., RET-KIF5B and 
RET-CCDC6) from 17 Japanese cases (Table 1). Ten of the 17 
cases, consisting of eight KIF5B-RET and two  CCDC6-RET 
cases, allowed amplification of reciprocal genomic seg-
ments using PCR primers set 1 kb away from the identified 
 KIF5B-RET or CCDC6-RET breakpoints. This indicated 
that these fusions were the results of simple reciprocal inver-
sions (cases 1–10 in Table 1, Fig. 2C). On the other hand, the 
remaining seven cases did not allow amplification of genomic 
segments encompassing the reciprocal breakpoint junctions 
(cases 11–16 and 18 in Table 1). Three of these seven cases, 
for which corresponding noncancerous DNA was available, 
were subjected to LOH analysis at the RET locus. LOH was 
detected at a region proximal (N-terminal) to the breakpoints 
in all three cases (cases 11, 15, and 16 in Table 1, Fig. 1A), 
indicating nonreciprocal inversion associated with deletion of 
a copy of the region proximal to the breakpoints. In addition, 
the inversion in the aforementioned Korean case (case 17) is 
also nonreciprocal.4 These data suggested that only a fraction 
of RET fusions (10 of 18, 56%) are caused by simple recipro-
cal inversions.
Modes of DNA End Joining That Give 
Rise to Reciprocal Inversions
Two major types of DNA repair pathways cause struc-
tural variations.11,12 The first type is nonhomologous end join-
ing (NHEJ) of DNA double strand breaks (DSBs). which 
requires very short (a few base pairs) or no homology, and 
often inserts a few nucleotides at breakpoint junctions.8,22,23 
NHEJ has canonical and noncanonical forms; in the latter, 
called alternative end joining, DNA ends are joined using 
microhomology of a few nucleotides at breakpoints.24 The 
second type includes repair pathways that use long (>10 bp) 
homology at DNA ends, such as break-induced replication 
(BIR) and nonallelic homologous recombination.12,25
Sequence analysis of breakpoint-containing genomic 
segments in 10 reciprocal cases revealed that deletions fre-
quently (8 of 10, 80%) occur in RET and/or its partner locus 
(i.e., KIF5B or CCDC6) upon DNA end joining (Table 1). 
This analysis also enabled us to deduce that both types of 
repair pathways described above are involved in these joining 
events. In six of the cases (cases 1–6 in Table 1), four DNA 
ends were joined, and in two cases, insertions were observed 
(representative cases in Supplementary Fig. 1, Supplementary 
Digital Content 3, http://links.lww.com/JTO/A543). The lack 
of significant homology between the sequences of the RET 
and KIF5B/CCDC6 breakpoints led us to deduce that DNA 
end joining was mediated by NHEJ in these six cases: two 
DSBs formed, one each in RET and its partner locus, and the 
four resultant DNA ends were illegitimately joined by canoni-
cal or noncanonical NHEJ (Fig. 3A).
The remaining four cases (cases 7–10 in Table 1) had a 
distinctive feature. DNA segments of 33 to 490 bp from either 
the RET or KIF5B locus were retained at both the KIF5B-
RET and RET-KIF5B breakpoints, resulting in duplication 
of these segments. Notably, two regions encompassing the 
breakpoint in a locus exhibited sequence homology to the 
duplicated segment of the other locus (representative cases 
in Supplementary Fig. 2, Supplementary Digital Content 
3, http://links.lww.com/JTO/A543). This feature led us to 
deduce that these joining events were mediated by BIR, using 
both DNA ends generated by DNA single-strand breaks at 
the RET or fusion-partner locus (Fig. 3B). Specifically, two 
DNA broken ends generated at the RET (or partner locus) 
annealed with the DSB sites of the fusion-partner (or RET) 
locus through sequence homology and were then subjected 
to ectopic DNA replication. This process left the same DNA 
segment at both breakpoint junctions, resulting in duplication 
of the segment.
Speculated Mode of DNA End Joining 
Giving Rise to Nonreciprocal Inversion
Our study also speculated about the modes of join-
ing involved in the eight remaining cases, which were not 
likely to have been subjected to simple reciprocal inversion 
and are therefore defined here as nonreciprocal (cases 11–18 
in Table 1). Due to the lack of sequence information from 
breakpoints in reciprocal counterparts, deletions could not be 
assessed. The lack of significant homology between the RET 
and KIF5B/CCDC6 breakpoints suggested the involvement of 
NHEJ. Consistent with this idea, insertion of a few nucleo-
tides, a common trace of NHEJ, was observed in three cases 
(cases 11, 15, and 17). A single case (case 16) had an inser-
tion of 349 nucleotides, corresponding to the inverted seg-
ment of RET exon 7 to intron 7, suggesting the occurrence of 
an unspecified complex rearrangement mediated by a process 
other than NHEJ, such as fork stalling and template switch-
ing (Lee et al., 2007). These results suggest that the predomi-
nant molecular process is illegitimate NHEJ repair, in which 
two DSBs are formed both in the RET and partner loci, and 
one end of the partner locus (the N-terminal part of KIF5B or 
CCDC6) and one end of the RET locus (the C-terminal part) 
are joined by NHEJ. Nevertheless, the remaining two DNA 
ends were not joined in a simple manner. DNA segments 
within the DNA ends were either lost or joined with DNA 
ends other than those at the RET, KIF5B, and CCDC6 loci, 
consistent with the observations of LOH at regions proximal 
to breakpoints in RET (Table 1). In fact, in case 17, the 3′ part 
of the KIF5B gene was fused to the KIAA1462 gene, 2.0 Mb 
away from KIF5B.4
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DISCUSSION
In this study, we investigated the molecular mechanisms 
underlying oncogenic RET fusion in LADCs. Distribution 
of breakpoints made us consider a 2.0-kb segment spanning 
RET exon 11 to intron 11 (and also a 5.6-kb segment spanning 
KIF5B intron 15) as a breakpoint cluster region(s). The break-
points in these regions were dispersed at intervals larger than 
4 bp. The inferred breakpoints do not necessarily indicate the 
sites of actual DNA breaks because resection of nucleotides 
from DNA ends sometimes occurs during the DNA repair.23 
In fact, we observed nucleotide deletions in eight of 10 
LADC cases with reciprocal KIF5B/CCDC6-RET inversions. 
Nevertheless, when the locations of putative breakpoints 
before DNA end resection were included, the breakpoint dis-
tribution remained scattered. These data strongly suggested 
that the majority of DNA breaks triggering RET fusions occur 
at nonspecific sites in defined regions of a few kb in size. 
Furthermore, this seems to hold true irrespective of etiology 
and tumor type: the distribution of breakpoints was not sig-
nificantly different between ever- and never-smokers, and RET 
exon 11 to intron 11 was also defined as a breakpoint cluster 
region for RET fusions in PTCs, as previously reported.14–17 
The cases shown in Figure 2 (gray and black arrowheads) 
include PTCs induced by post-Chernobyl irradiation, in which 
DNA breaks were presumably caused exclusively by irradia-
tion; the random breakpoint distributions in these PTCs were 
similar to those of the LADCs we analyzed.
We investigated the DNA end-joining pathways that gave 
rise to RET fusions by analyzing the structures of breakpoint junc-
tions. NHEJ was found to be one of the major pathways of DNA 
end joining. We and others also showed that NHEJ is also promi-
nently involved in interstitial deletions that inactivate tumor-sup-
pressor genes, such as CDKN2A/p16 and STK11/LKB1, in lung 
cancer.13,26,27 Thus, NHEJ contributes to the occurrence of driver 
mutations in both tumor-suppressor genes and oncogenes during 
lung carcinogenesis. Our data also reveal a possible contribution 
of BIR in DNA end joining to generate reciprocal inversions. 
We deduced that BIR occurred from DNA ends, probably gener-
ated by DNA  single-strand breaks, in the RET or partner locus, 
beginning with annealing with the other locus through nucleo-
tide homologies of tens to hundreds of base pairs. This process 
resulted in duplication of breakpoint-flanking DNA segments of 
tens to hundreds of base pairs. BIR has recently been implicated 
in oncogenic RAF fusions in pediatric brain tumors.28 In those 
cases, the sequence homology used for annealing of DNA ends 
was on the order of a few base pairs. Thus, BIR might generate 
oncogenic fusions frequently, although the detailed process may 
differ according to tumor type.
Irrespective of the similarities in breakpoint distri-
bution, several processes involved in RET fusions differed 
between LADC and PTC (Fig. 4). Reciprocal inversion was 
unlikely to have occurred by BIR in PTC because none of 
the PTC cases exhibited the duplication of DNA segments 
that were observed in LADC; therefore, the joining of DNA 
ends in PTC was likely to have been mediated exclusively by 
NHEJ.17 This is plausible because RET fusions preferentially 
occur in PTCs in patients suffering from high-dose radia-
tion exposure, suggesting that DSBs generated at the RET or 
partner loci triggered the chromosome rearrangements that 
generated RET fusions.29 Repetitive NHEJ repair of abundant 
FIGURE 3.  Deduced processes of reciprocal 
inversion by NHEJ and BIR. A, NHEJ. Four DNA 
ends generated by DSBs at RET and a partner 
locus were directly joined. Often, insertions of 
nucleotides (NNN) at breakpoint junctions are 
observed. B, BIR. Here, DNA single-strand breaks 
(SSBs) occur in the KIF5B locus and a DSB occurs 
in the RET locus. The two SSBs at the KIF5B locus 
trigger BIR by annealing at two homologous sites 
in the RET locus. BIR results in duplication of a 
KIF5B segment. As a result, the RET breakpoints in 
the KIF5B-RET and RET-KIF5B fusions are located at 
the same position (a DSB site), whereas the KIF5B 
breakpoints in these fusions are located at differ-
ent positions (two SSB sites). ▽, breakpoints for 
partner-RET fusion; ▲, breakpoints for RET-partner 
fusion. NHEJ, nonhomologous end joining; BIR, 
break-induced replication.
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DSBs, which occurs in the context of irradiation, may increase 
the likelihood of illegitimate repair generating RET fusion. On 
the other hand, in LADC, both DSBs and single-strand breaks 
formed by multiple causes might trigger rearrangements by 
multiple DNA repair pathways. The high frequency of non-
reciprocal inversion also distinguishes LADC from PTC, for 
previous study revealed that RET fusions result from recip-
rocal inversion in most cases (43 of 47, 91%).14,15 Frequent 
nonreciprocal inversion is consistent with the observation that 
KIF5B-RET fusion-positive tumors contain deletions of the 5′ 
part of RET, as revealed by FISH staining patterns.1 The pres-
ent study provides a molecular basis for such a distinct FISH 
finding and will help to define the criteria used to diagnose 
RET-fusion-positive LADC. Interestingly, FISH analysis also 
revealed that another driver mutation, EML4-ALK fusion, in 
LADC, caused by a paracentric inversion of chromosome 2, 
also involves deletion of the 5′ region of the ALK oncogene 
locus.30,31 Although the structures of breakpoint junctions of 
ALK fusions have not been characterized to the best of our 
knowledge, these results indicate that a significant fraction of 
chromosome inversions that cause oncogenic fusions in lung 
cancer are likely to be nonreciprocal.
Finally, a few issues remain to be elucidated regarding the 
molecular processes generating oncogenic RET fusions. First, 
although this and previous PTC studies imply that the 2.0-kb 
region spanning the RET exon 11 to intron 11 region is suscep-
tible to DNA strand breaks, the underlying mechanisms remain 
unknown. For, this region does not exhibit distinctive features 
known to make DNA susceptible to breaks (Supplementary 
Fig. 3, Supplementary Digital Content 3, http://links.lww.com/
JTO/A543; details in Supplementary Notes, Supplementary 
Digital Content 2, http://links.lww.com/JTO/A542). Second, 
the etiological factors that cause DNA strand breaks, and the 
factors that determine reciprocal or nonreciprocal inversion 
and selection of DNA repair pathways, also remain unknown. 
The mode of joining and breakpoint distribution was irrespec-
tive of smoking history, and therefore, DNA damage due to 
smoking is unlikely to be an important factor. The fact that 
RET fusions are more frequent in LADC of never-smokers 
than in that of ever-smokers indicates that undefined etiologi-
cal factors play major roles in the occurrence of RET fusions.
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